Moscow, Russia

Viktoriya Isaakovna Levina

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Obschestvo S Ogranichennoy Otvetstvennostyu “Polyar” (Ooo Polyar). Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viktoriya Isaakovna Levina. Retrieved from https://idiyas.com/inventor/viktoriya-isaakovna-levina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Viktoriya Isaakovna Levina: Innovator in Biologically Active Compounds

Introduction

Viktoriya Isaakovna Levina is a prominent inventor based in Moscow, Russia. She has made significant contributions to the chemical-pharmaceutical industry and medicine. Her work focuses on developing biologically active compounds with therapeutic applications.

Latest Patents

Viktoriya holds a patent for a compound known as N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride. This compound exhibits anti-inflammatory and chondroprotective activity. Notably, it does not exhibit adverse effects, making it a promising candidate for medical applications.

Career Highlights

Viktoriya is associated with the company Polyar, where she continues to advance her research and development efforts. Her innovative work has the potential to impact the treatment of various inflammatory conditions.

Collaborations

Viktoriya collaborates with notable colleagues, including Svetlana Yurevna Ryabova and Valery Aleksandrovich Parshin. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Viktoriya Isaakovna Levina is a dedicated inventor whose work in biologically active compounds is paving the way for new therapeutic options. Her contributions to the field are noteworthy and reflect her commitment to innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…